Molecular Requirements for the Expression of Antiplatelet Effects by Synthetic Structural Optimized Analogues of the Anticancer Drugs Imatinib and Nilotinib

Molecular Requirements for the Expression of Antiplatelet Effects by Synthetic Structural Optimized Analogues of the Anticancer Drugs Imatinib and Nilotinib

Despoina Pantazi,1 Nikoleta Ntemou,2 Alexios Brentas,2 Dimitrios Alivertis,3 Konstantinos Skobridis,2 Alexandros D Tselepis1 1Department of Chemistry, Atherothrombosis Research Centre, Laboratory of Biochemistry, University of Ioannina, Ioannina 45110, Greece; 2Department of Chemistry, Section of Or...

Full description

Bibliographic Details
Main Authors: Pantazi D, Ntemou N, Brentas A, Alivertis D, Skobridis K, Tselepis AD
Format: Article
Language:English
Published: Dove Medical Press 2019-12-01
Series:Drug Design, Development and Therapy
Subjects:
cancer
kinase inhibitors
platelets
synthesis
thrombosis
Online Access:https://www.dovepress.com/molecular-requirements-for-the-expression-of-antiplatelet-effects-by-s-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/molecular-requirements-for-the-expression-of-antiplatelet-effects-by-s-peer-reviewed-article-DDDT

Similar Items